Dr. Nathan S Bryan

Dr. Bryan earned his undergraduate Bachelor of Science degree in Biochemistry from the University of Texas at Austin and his doctoral degree from Louisiana State University School of Medicine in Shreveport, where he was the recipient of the Dean’s Award for Excellence in Research.

He pursued his post-doctoral training as a Kirschstein Fellow at Boston University School of Medicine in the Whitaker Cardiovascular Institute. After a two-year post-doctoral fellowship, in 2006 Dr. Bryan was recruited to join the faculty at the University of Texas Health Science Center at Houston by Ferid Murad, M.D., Ph.D., 1998 Nobel Laureate in Medicine or Physiology.

Dr. Bryan has been involved in nitric oxide research for the past 25 years and has made many seminal discoveries in the field. He is a successful entrepreneur and Founder, Chairman, and CEO of Bryan Therapeutics, Inc., a privately-held, clinical-stage biotechnology company actively engaged in the discovery and development of nitric oxide-based therapies.

BTI has active drug development programs in heart disease, Alzheimer’s disease, and topical drugs for diabetic ulcers and non-healing wounds. Dr. Bryan’s consumer line of products includes some of the most successful nitric oxide products on the market.

He is recognized as an international leader in molecular medicine and nitric oxide biochemistry.